Clinical trials
Dyslipidemias trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 8 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 11 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 13 |
| 2019 | 14 |
| 2020 | 9 |
| 2021 | 12 |
| 2022 | 13 |
| 2023 | 10 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 144 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Toronto | 5 |
| Chong Kun Dang Pharmaceutical | 4 |
| German Institute of Human Nutrition | 4 |
| IlDong Pharmaceutical Co Ltd | 4 |
| John Sievenpiper | 4 |
| Aga Khan University | 3 |
| Assiut University | 3 |
| Daewoong Pharmaceutical Co. LTD. | 3 |
| Yooyoung Pharmaceutical Co., Ltd. | 3 |
| Azienda Ospedaliera Universitaria Integrata Verona | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 144 |
| Hypertension | 51 |
| Obesity | 39 |
| Diabetes Mellitus | 30 |
| Cardiovascular Diseases | 26 |
| Metabolic Syndrome | 24 |
| Diabetes Mellitus, Type 2 | 20 |
| Insulin Resistance | 13 |
| Non-alcoholic Fatty Liver Disease | 13 |
| Prediabetic State | 13 |
Trials
Showing 26 to 50 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.